STOCK TITAN

[144] Sera Prognostics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Sera Prognostics' Form 144 shows a proposed sale of 7,094 Class A Common shares through Morgan Stanley Smith Barney on 08/08/2025. The filing states these shares were acquired by Restricted Stock Unit vesting on 08/08/2025 and lists an aggregate market value of 18,021 with 38,061,868 shares outstanding. The filing also discloses sales in the past three months: 5,132 shares on 05/08/2025 (gross proceeds 12,535) and 1,439 shares on 06/10/2025 (gross proceeds 2,136), totaling 6,571 shares sold for 14,671 gross proceeds. The notice includes the required representation that the seller does not possess undisclosed material adverse information.

Il Form 144 di Sera Prognostics segnala una proposta di vendita di 7,094 azioni ordinarie di Classe A tramite Morgan Stanley Smith Barney in data 08/08/2025. La comunicazione indica che queste azioni sono state acquisite tramite vesting di Restricted Stock Units il 08/08/2025 e riporta un valore di mercato aggregato di 18,021 con 38,061,868 azioni in circolazione. Il documento dichiara inoltre vendite nei tre mesi precedenti: 5,132 azioni il 05/08/2025 (proventi lordi 12,535) e 1,439 azioni il 06/10/2025 (proventi lordi 2,136), per un totale di 6,571 azioni vendute per 14,671 di proventi lordi. L'avviso include la dichiarazione richiesta che il venditore non possiede informazioni materiali adverse non divulgate.

El Form 144 de Sera Prognostics muestra una propuesta de venta de 7,094 acciones ordinarias Clase A a través de Morgan Stanley Smith Barney el 08/08/2025. La presentación indica que estas acciones fueron adquiridas por vesting de Restricted Stock Units el 08/08/2025 y lista un valor de mercado agregado de 18,021 con 38,061,868 acciones en circulación. El documento también revela ventas en los últimos tres meses: 5,132 acciones el 05/08/2025 (ingresos brutos 12,535) y 1,439 acciones el 06/10/2025 (ingresos brutos 2,136), sumando 6,571 acciones vendidas por 14,671 de ingresos brutos. La notificación incluye la declaración requerida de que el vendedor no posee información adversa material no divulgada.

Sera Prognostics의 Form 144는 Morgan Stanley Smith Barney를 통해 7,094주 Class A 보통주08/08/2025에 매도 제안한 것으로 기재되어 있습니다. 제출서류에는 해당 주식이 제한주식단위(Restricted Stock Unit)의 베스팅으로 08/08/2025에 취득되었고, 총 시가 18,02138,061,868주 발행으로 기재되어 있습니다. 서류는 또한 지난 3개월간의 매도 내역을 공시합니다: 05/08/2025에 5,132주 (총 매각대금 12,535) 및 06/10/2025에 1,439주 (총 매각대금 2,136), 합계 6,571주를 매도하여 총 매각대금 14,671을 기록했습니다. 이 통지는 판매자가 공개되지 않은 중요한 불리한 정보를 보유하고 있지 않다는 필수 진술을 포함하고 있습니다.

Le formulaire 144 de Sera Prognostics indique une proposition de vente de 7,094 actions ordinaires de catégorie A par l'intermédiaire de Morgan Stanley Smith Barney le 08/08/2025. Le dossier précise que ces actions ont été acquises par vesting d'unités d'actions restreintes le 08/08/2025 et mentionne une valeur marchande agrégée de 18,021 avec 38,061,868 actions en circulation. Le dépôt révèle également des ventes au cours des trois derniers mois : 5,132 actions le 05/08/2025 (produits bruts 12,535) et 1,439 actions le 06/10/2025 (produits bruts 2,136), soit au total 6,571 actions vendues pour 14,671 de produits bruts. L'avis inclut la déclaration requise selon laquelle le vendeur ne dispose d'aucune information défavorable matérielle non divulguée.

Das Form 144 von Sera Prognostics weist einen geplanten Verkauf von 7,094 Class A Stammaktien über Morgan Stanley Smith Barney am 08/08/2025 aus. Die Einreichung gibt an, dass diese Aktien durch Vesting von Restricted Stock Units am 08/08/2025 erworben wurden und nennt einen aggregierten Marktwert von 18,021 bei 38,061,868 ausstehenden Aktien. Die Einreichung offenbart außerdem Verkäufe in den letzten drei Monaten: 5,132 Aktien am 05/08/2025 (Bruttoerlös 12,535) und 1,439 Aktien am 06/10/2025 (Bruttoerlös 2,136), insgesamt 6,571 Aktien verkauft für 14,671 Bruttoerlös. Die Mitteilung enthält die erforderliche Erklärung, dass der Verkäufer keine nicht offengelegten wesentlichen negativen Informationen besitzt.

Positive
  • The shares to be sold were acquired by Restricted Stock Unit vesting, indicating no cash purchase for the acquisition.
  • The proposed sale of 7,094 shares represents approximately 0.019% of the reported 38,061,868 shares outstanding, suggesting immaterial dilution.
Negative
  • None.

Insights

TL;DR: Proposed 7,094‑share sale is small relative to the 38,061,868 shares outstanding (about 0.019%).

The Form 144 shows the 7,094 shares to be sold were acquired via RSU vesting on 08/08/2025 and are to be sold through Morgan Stanley Smith Barney on the same date. Relative to the reported 38,061,868 shares outstanding, the proposed sale represents approximately 0.019% of outstanding shares, indicating the transaction is immaterial from a dilution perspective. The filing also documents two prior sales in the last three months totaling 6,571 shares and aggregate gross proceeds of 14,671, which similarly represent a very small fraction of outstanding stock.

TL;DR: This is a routine insider sale tied to RSU vesting and includes the standard certification about undisclosed material adverse information.

The submission is a standard Form 144 disclosure for shares acquired by restricted stock unit vesting and slated for sale via a broker. The document contains the required seller representation that no undisclosed material adverse information is known. Given the small absolute size of the proposed sale versus total shares outstanding, the filing appears procedural rather than indicative of a material governance or disclosure concern.

Il Form 144 di Sera Prognostics segnala una proposta di vendita di 7,094 azioni ordinarie di Classe A tramite Morgan Stanley Smith Barney in data 08/08/2025. La comunicazione indica che queste azioni sono state acquisite tramite vesting di Restricted Stock Units il 08/08/2025 e riporta un valore di mercato aggregato di 18,021 con 38,061,868 azioni in circolazione. Il documento dichiara inoltre vendite nei tre mesi precedenti: 5,132 azioni il 05/08/2025 (proventi lordi 12,535) e 1,439 azioni il 06/10/2025 (proventi lordi 2,136), per un totale di 6,571 azioni vendute per 14,671 di proventi lordi. L'avviso include la dichiarazione richiesta che il venditore non possiede informazioni materiali adverse non divulgate.

El Form 144 de Sera Prognostics muestra una propuesta de venta de 7,094 acciones ordinarias Clase A a través de Morgan Stanley Smith Barney el 08/08/2025. La presentación indica que estas acciones fueron adquiridas por vesting de Restricted Stock Units el 08/08/2025 y lista un valor de mercado agregado de 18,021 con 38,061,868 acciones en circulación. El documento también revela ventas en los últimos tres meses: 5,132 acciones el 05/08/2025 (ingresos brutos 12,535) y 1,439 acciones el 06/10/2025 (ingresos brutos 2,136), sumando 6,571 acciones vendidas por 14,671 de ingresos brutos. La notificación incluye la declaración requerida de que el vendedor no posee información adversa material no divulgada.

Sera Prognostics의 Form 144는 Morgan Stanley Smith Barney를 통해 7,094주 Class A 보통주08/08/2025에 매도 제안한 것으로 기재되어 있습니다. 제출서류에는 해당 주식이 제한주식단위(Restricted Stock Unit)의 베스팅으로 08/08/2025에 취득되었고, 총 시가 18,02138,061,868주 발행으로 기재되어 있습니다. 서류는 또한 지난 3개월간의 매도 내역을 공시합니다: 05/08/2025에 5,132주 (총 매각대금 12,535) 및 06/10/2025에 1,439주 (총 매각대금 2,136), 합계 6,571주를 매도하여 총 매각대금 14,671을 기록했습니다. 이 통지는 판매자가 공개되지 않은 중요한 불리한 정보를 보유하고 있지 않다는 필수 진술을 포함하고 있습니다.

Le formulaire 144 de Sera Prognostics indique une proposition de vente de 7,094 actions ordinaires de catégorie A par l'intermédiaire de Morgan Stanley Smith Barney le 08/08/2025. Le dossier précise que ces actions ont été acquises par vesting d'unités d'actions restreintes le 08/08/2025 et mentionne une valeur marchande agrégée de 18,021 avec 38,061,868 actions en circulation. Le dépôt révèle également des ventes au cours des trois derniers mois : 5,132 actions le 05/08/2025 (produits bruts 12,535) et 1,439 actions le 06/10/2025 (produits bruts 2,136), soit au total 6,571 actions vendues pour 14,671 de produits bruts. L'avis inclut la déclaration requise selon laquelle le vendeur ne dispose d'aucune information défavorable matérielle non divulguée.

Das Form 144 von Sera Prognostics weist einen geplanten Verkauf von 7,094 Class A Stammaktien über Morgan Stanley Smith Barney am 08/08/2025 aus. Die Einreichung gibt an, dass diese Aktien durch Vesting von Restricted Stock Units am 08/08/2025 erworben wurden und nennt einen aggregierten Marktwert von 18,021 bei 38,061,868 ausstehenden Aktien. Die Einreichung offenbart außerdem Verkäufe in den letzten drei Monaten: 5,132 Aktien am 05/08/2025 (Bruttoerlös 12,535) und 1,439 Aktien am 06/10/2025 (Bruttoerlös 2,136), insgesamt 6,571 Aktien verkauft für 14,671 Bruttoerlös. Die Mitteilung enthält die erforderliche Erklärung, dass der Verkäufer keine nicht offengelegten wesentlichen negativen Informationen besitzt.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does SERA's Form 144 report?

The form reports a proposed sale of 7,094 Class A Common shares through Morgan Stanley Smith Barney on 08/08/2025 and prior sales in the past three months.

Who is the seller listed on the filing for SERA?

The seller shown in the past-sales section is John J. Boniface (address listed in the filing).

How were the 7,094 SERA shares acquired?

The filing states the shares were acquired on 08/08/2025 by Restricted Stock Unit vesting from the issuer.

What prior insider sales are disclosed for SERA?

Two prior sales are disclosed: 5,132 shares on 05/08/2025 (gross proceeds 12,535) and 1,439 shares on 06/10/2025 (gross proceeds 2,136), totaling 6,571 shares and 14,671 gross proceeds.

What are the aggregate market value and shares outstanding listed?

The filing lists an aggregate market value of 18,021 for the proposed sale and 38,061,868 shares outstanding.
Sera Prognostics, Inc.

NASDAQ:SERA

SERA Rankings

SERA Latest News

SERA Latest SEC Filings

SERA Stock Data

103.60M
32.79M
11.53%
73.64%
3.61%
Medical Devices
Services-medical Laboratories
Link
United States
SALT LAKE CITY